Role of asenapine as an augmenter for treatment-resistant schizophrenia
Psychiatry Research Case Reports · 2022
DOI: 10.1016/j.psycr.2022.100019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry Research Case Reports, 2022. Verfasst von Wisam Al Jumaili und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Case reportMs.C is a 35-year-old single Caucasian female with TRS admitted involuntarily to an inpatient psychiatric hospital for stabilization after showing disorganized behavior and speech.For the last 12 years, Ms. C carries a diagnosis of schizophrenia, the patient has been treated at high-security hospitals with multiple admissions and high dose, high
Zitieren
APA
Jumaili, W. A., & Jain, S. (2022). Role of asenapine as an augmenter for treatment-resistant schizophrenia. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100019
Vancouver
Jumaili WA, Jain S. Role of asenapine as an augmenter for treatment-resistant schizophrenia. Psychiatry Research Case Reports. 2022. doi:10.1016/j.psycr.2022.100019
BibTeX
@article{Jumaili2022,
author = {Jumaili, Wisam Al and Jain, Shailesh},
title = {Role of asenapine as an augmenter for treatment-resistant schizophrenia},
journal = {Psychiatry Research Case Reports},
year = {2022},
doi = {10.1016/j.psycr.2022.100019}
}
EUVIMED